Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Methylphenidate improves attention, behavior of children surviving leukemia, brain tumors

02.12.2004


St. Jude study shows three-week treatment with methylphenidate led to significant improvement of attention and behavior problems due to central nervous system exposure to radiation, chemotherapy



Children who suffer from behavioral and learning problems after their central nervous systems have been exposed to chemotherapy or radiation appear to benefit from treatment with methylphenidate (MPH), the drug commonly known by the brand name Ritalin®. This finding, from investigators at St. Jude Children’s Research Hospital, are published in the Dec. 1 issue of the Journal of Clinical Oncology (JCO).

The study suggests that MPH can at least temporarily reduce some of the attention and social deficits among survivors of childhood acute lymphoblastic leukemia (ALL) and brain tumors (BTs), the two most common forms of childhood cancer.


Previous studies have shown that these children are likely to develop significant cognitive and behavioral problems compared to their healthy peers, according to Raymond K. Mulhern, Ph.D., chief of St. Jude Behavioral Medicine. Mulhern is lead author of JCO report.

"Our three-week study gave us promising results for children suffering from attention and behavior problems due to their cancer treatments," Mulhern said. "Our future plans include follow-up evaluations of children who continue MPH treatment for three, six and 12 months. In addition to improvements in learning and behavior, we would also like to know if such treatment results in structural changes in the brain, as hypothesized by other researchers."

The St. Jude study is the first to examine the ability of two doses of MPH to reduce these problems at home and in the classroom among childhood cancer survivors.

The study included 83 long-term survivors, 40 of whom had survived ALL and 43 of whom survived BTs. The children (47 males and 36 females) were identified as having attention deficits as measured by specific tests and according to both parent and teacher reports. They ranged in age from six months to 14.3 years when they were first diagnosed with cancer, and 6.7 to 17.9 years when they were in the study.

The researchers identified specific children as having attention or behavior problems through various tests, such as the Wechsler scales (IQ tests) and Conner’s Continuous Performance Test (selective and sustained attention, reaction time and level of impulsiveness). Each patient who agreed to participate was then randomly assigned to one of six sequences for a three-week course of treatment with MPH. Each sequence included a low dose of MPH (0.3 mg/kg of body weight), a moderate dose of MPH (0.6 mg/kg of body weight) and a placebo in one of the sequences (e.g., low dose, placebo, high dose). The drug and placebo were administered at school.

The effect of MPH on children in the study was measured by both teachers and parents, who used the Conners’ Rating Scales, and teachers who used the Social Skills Rating System to assess the children. Both teachers and parents reported that, compared to placebo, MPH significantly improved the attention and behavioral problems, although the moderate dose was not consistently more effective than the low dose.

"The treatment of children with ALL and brain tumor shouldn’t end after the cancer has been eradicated," said Wilburn E. Reddick, Ph.D., director of the diagnostic and signal processing laboratory at St. Jude and co-principal investigator. "This study has shown that follow-up therapy with MPH might help resolve some of the serious side-effects of cancer treatment."

Other authors of this paper are Raja B. Khan, Stuart Kaplan, Susan Helton, Robbin Christensen, Xiaoping Xiong and Sengjie Wu (St. Jude); Melanie Bonner and Sridharan Gururangan (Duke University, Durham, NC); and Ronald Brown (Temple University, Philadelphia, PA).

Bonnie Cameron | EurekAlert!
Further information:
http://www.stjude.org

More articles from Health and Medicine:

nachricht Penn study identifies new malaria parasites in wild bonobos
21.11.2017 | University of Pennsylvania School of Medicine

nachricht NIST scientists discover how to switch liver cancer cell growth from 2-D to 3-D structures
17.11.2017 | National Institute of Standards and Technology (NIST)

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Nanoparticles help with malaria diagnosis – new rapid test in development

The WHO reports an estimated 429,000 malaria deaths each year. The disease mostly affects tropical and subtropical regions and in particular the African continent. The Fraunhofer Institute for Silicate Research ISC teamed up with the Fraunhofer Institute for Molecular Biology and Applied Ecology IME and the Institute of Tropical Medicine at the University of Tübingen for a new test method to detect malaria parasites in blood. The idea of the research project “NanoFRET” is to develop a highly sensitive and reliable rapid diagnostic test so that patient treatment can begin as early as possible.

Malaria is caused by parasites transmitted by mosquito bite. The most dangerous form of malaria is malaria tropica. Left untreated, it is fatal in most cases....

Im Focus: A “cosmic snake” reveals the structure of remote galaxies

The formation of stars in distant galaxies is still largely unexplored. For the first time, astron-omers at the University of Geneva have now been able to closely observe a star system six billion light-years away. In doing so, they are confirming earlier simulations made by the University of Zurich. One special effect is made possible by the multiple reflections of images that run through the cosmos like a snake.

Today, astronomers have a pretty accurate idea of how stars were formed in the recent cosmic past. But do these laws also apply to older galaxies? For around a...

Im Focus: Visual intelligence is not the same as IQ

Just because someone is smart and well-motivated doesn't mean he or she can learn the visual skills needed to excel at tasks like matching fingerprints, interpreting medical X-rays, keeping track of aircraft on radar displays or forensic face matching.

That is the implication of a new study which shows for the first time that there is a broad range of differences in people's visual ability and that these...

Im Focus: Novel Nano-CT device creates high-resolution 3D-X-rays of tiny velvet worm legs

Computer Tomography (CT) is a standard procedure in hospitals, but so far, the technology has not been suitable for imaging extremely small objects. In PNAS, a team from the Technical University of Munich (TUM) describes a Nano-CT device that creates three-dimensional x-ray images at resolutions up to 100 nanometers. The first test application: Together with colleagues from the University of Kassel and Helmholtz-Zentrum Geesthacht the researchers analyzed the locomotory system of a velvet worm.

During a CT analysis, the object under investigation is x-rayed and a detector measures the respective amount of radiation absorbed from various angles....

Im Focus: Researchers Develop Data Bus for Quantum Computer

The quantum world is fragile; error correction codes are needed to protect the information stored in a quantum object from the deteriorating effects of noise. Quantum physicists in Innsbruck have developed a protocol to pass quantum information between differently encoded building blocks of a future quantum computer, such as processors and memories. Scientists may use this protocol in the future to build a data bus for quantum computers. The researchers have published their work in the journal Nature Communications.

Future quantum computers will be able to solve problems where conventional computers fail today. We are still far away from any large-scale implementation,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Ecology Across Borders: International conference brings together 1,500 ecologists

15.11.2017 | Event News

Road into laboratory: Users discuss biaxial fatigue-testing for car and truck wheel

15.11.2017 | Event News

#Berlin5GWeek: The right network for Industry 4.0

30.10.2017 | Event News

 
Latest News

Previous evidence of water on mars now identified as grainflows

21.11.2017 | Physics and Astronomy

NASA's James Webb Space Telescope completes final cryogenic testing

21.11.2017 | Physics and Astronomy

New catalyst controls activation of a carbon-hydrogen bond

21.11.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>